Literature DB >> 14631457

A new method for rapidly and simultaneously decreasing serotonin and catecholamine synthesis in humans.

Marco Leyton1, Valerie Kwai Pun, Chawki Benkelfat, Simon N Young.   

Abstract

OBJECTIVE: The administration of amino acid (AA) mixtures that are selectively deficient either in tryptophan or phenylalanine plus tyrosine can decrease serotonin or catecholamine synthesis, respectively. In the present study, we assessed whether a mixture that was simultaneously deficient in tryptophan, phenylalanine and tyrosine could induce sufficient protein synthesis that plasma levels of all 3 monoamine precursors would decrease.
DESIGN: Ten healthy volunteers (5 male, 5 female) were administered a tryptophan/phenylalanine/tyrosine-deficient AA mixture in an open-label study. Plasma concentrations of large neutral AAs were measured before and 5 hours after mixture ingestion.
RESULTS: The tryptophan/phenylalanine/tyrosine-deficient mixture lowered plasma concentrations of the 3 AAs by 67;, 78% and 77%, respectively (p < or = 0.001); their ratio to other large neutral AAs was decreased more, namely, by 87%, 90% and 90% (p < or = 0.001). Mood lowering was seen on 3 subscales of the bipolar Profile of Mood States, that is, elated-depressed, composed-anxious and clearheaded-confused, as well as 2 visual analog scales, bored and irritated (p < or = 0.05).
CONCLUSIONS: Acute tryptophan/phenylalanine/tyrosine depletion may be a suitable new method for rapidly decreasing serotonin and catecholamine transmission simultaneously.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14631457      PMCID: PMC257796     

Source DB:  PubMed          Journal:  J Psychiatry Neurosci        ISSN: 1180-4882            Impact factor:   6.186


  19 in total

1.  Effects on mood of acute phenylalanine/tyrosine depletion in healthy women.

Authors:  M Leyton; S N Young; R O Pihl; S Etezadi; C Lauze; P Blier; G B Baker; C Benkelfat
Journal:  Neuropsychopharmacology       Date:  2000-01       Impact factor: 7.853

2.  An amino acid mixture deficient in phenylalanine and tyrosine reduces cerebrospinal fluid catecholamine metabolites and alcohol consumption in vervet monkeys.

Authors:  R M Palmour; F R Ervin; G B Baker; S N Young
Journal:  Psychopharmacology (Berl)       Date:  1998-03       Impact factor: 4.530

3.  The family history method using diagnostic criteria. Reliability and validity.

Authors:  N C Andreasen; J Endicott; R L Spitzer; G Winokur
Journal:  Arch Gen Psychiatry       Date:  1977-10

Review 4.  The role of serotonin in human mood and social interaction. Insight from altered tryptophan levels.

Authors:  Simon N Young; Marco Leyton
Journal:  Pharmacol Biochem Behav       Date:  2002-04       Impact factor: 3.533

Review 5.  Depressions following reserpine: a reevaluation.

Authors:  F K Goodwin; W E Bunney
Journal:  Semin Psychiatry       Date:  1971-11

6.  Evidence for bipolar mood states.

Authors:  M Lorr; D M McNair; S U Fisher
Journal:  J Pers Assess       Date:  1982-08

7.  Striatal dopaminergic and serotonergic markers in human heroin users.

Authors:  S J Kish; K S Kalasinsky; P Derkach; G A Schmunk; M Guttman; L Ang; V Adams; Y Furukawa; J W Haycock
Journal:  Neuropsychopharmacology       Date:  2001-05       Impact factor: 7.853

8.  Effect of a tyrosine-free amino acid mixture on regional brain catecholamine synthesis and release.

Authors:  S F McTavish; P J Cowen; T Sharp
Journal:  Psychopharmacology (Berl)       Date:  1999-01       Impact factor: 4.530

Review 9.  alpha-Methyl-p-tyrosine: a review of its pharmacology and clinical use.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1981-02       Impact factor: 9.546

10.  Decreasing amphetamine-induced dopamine release by acute phenylalanine/tyrosine depletion: A PET/[11C]raclopride study in healthy men.

Authors:  Marco Leyton; Alain Dagher; Isabelle Boileau; Kevin Casey; Glen B Baker; Mirko Diksic; Roger Gunn; Simon N Young; Chawki Benkelfat
Journal:  Neuropsychopharmacology       Date:  2004-02       Impact factor: 7.853

View more
  2 in total

1.  Acute dopamine and/or serotonin depletion does not modulate mismatch negativity (MMN) in healthy human participants.

Authors:  Sumie Leung; Rodney J Croft; Valérie Guille; Kirsty Scholes; Barry V O'Neill; K Luan Phan; Pradeep J Nathan
Journal:  Psychopharmacology (Berl)       Date:  2009-12-10       Impact factor: 4.530

2.  Specificity of the acute tryptophan and tyrosine plus phenylalanine depletion and loading tests I. Review of biochemical aspects and poor specificity of current amino Acid formulations.

Authors:  Abdulla A-B Badawy; Donald M Dougherty; Dawn M Richard
Journal:  Int J Tryptophan Res       Date:  2010-01-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.